Supportive Care in Cancer

, Volume 18, Issue 9, pp 1229–1230 | Cite as

Aprepitant against pruritus in patients with solid tumours

  • Bruno Vincenzi
  • Maria Elisabetta Fratto
  • Daniele Santini
  • Giuseppe Tonini
Short Communication

Keywords

Aprepipant Neurokinin-1 receptor Pruritus 

References

  1. 1.
    Navari RM (2009) Antiemetic control: toward a new standard of care for emetogenic chemotherapy. Expert Opin Pharmacother 10(4):629–644CrossRefPubMedGoogle Scholar
  2. 2.
    Saito R, Takano Y, Kamiya HO (2003) Roles of substance P and NK(1) receptor in brain stem in the development of emesis. J Pharmacol Sci 91:87–94CrossRefPubMedGoogle Scholar
  3. 3.
    Reddy GK, Gralla RJ, Hesketh PJ (2006) Novel neurokinin-1 antagonists as antiemetics for the treatment of chemotherapy-induced emesis. Support Cancer Ther 1(3):140–142CrossRefGoogle Scholar
  4. 4.
    Weldon D (2007) What lies beneath the surface of the itch in adults? Allergy Asthma Proc 28(2):153–162CrossRefPubMedGoogle Scholar
  5. 5.
    Duval A, Dubertret L (2009) Aprepitant as an antipruritic agent? N Engl J Med 361(14):1415–1416CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Bruno Vincenzi
    • 1
  • Maria Elisabetta Fratto
    • 1
  • Daniele Santini
    • 1
  • Giuseppe Tonini
    • 1
  1. 1.Medical OncologyUniversity Campus Bio-Medico, RomeRomeItaly

Personalised recommendations